22 julio 2015
When asked about administering the clot-busting drug tissue plasminogen activator to stroke patients, hospital staff perceptions did not always line up with actual performance. Only 29 percent of hospital staff accurately identified their ‘door-to-needle’ performance.img src=»http://feeds.feedburner.com/~r/sciencedaily/~4/VwMLn2Ax0Ws» height=»1″ width=»1″ alt=»»/
http://feeds.sciencedaily.com/~r/sciencedaily/~3/VwMLn2Ax0Ws/150722164227.htm
